David Toung
Stock Analyst at Argus Research
(4.56)
# 983
Out of 4,634 analysts
342
Total ratings
64.5%
Success rate
9.3%
Average return
Main Sectors:
Stocks Rated by David Toung
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HCA HCA Healthcare | Maintained: Buy | $500 | $414.03 | +20.76% | 5 | Aug 7, 2026 | |
| PFE Pfizer | Maintained: Buy | n/a | $27.05 | - | 13 | Aug 5, 2026 | |
| BSX Boston Scientific | Downgraded: Hold | n/a | $50.46 | - | 11 | Jul 30, 2026 | |
| JNJ Johnson & Johnson | Rated: Buy | $210 → $300 | $261.81 | +14.59% | 14 | Jul 28, 2026 | |
| DGX Quest Diagnostics | Maintained: Buy | $175 → $260 | $237.63 | +9.41% | 3 | Jul 28, 2026 | |
| DHR Danaher | Rated: Buy | $230 | $209.37 | +9.85% | 6 | Jul 23, 2026 | |
| UNH UnitedHealth Group | Maintained: Buy | $400 → $470 | $408.74 | +14.99% | 15 | Jul 17, 2026 | |
| SYK Stryker | Rated: Buy | $450 → $370 | $345.81 | +7.00% | 12 | Jul 9, 2026 | |
| IART Integra LifeSciences Holdings | Upgraded: Buy | $25 | $17.07 | +46.46% | 7 | Jun 17, 2026 | |
| LH Labcorp Holdings | Maintained: Buy | $310 | $321.31 | -3.52% | 3 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $241.99 | - | 5 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $92.03 | - | 2 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $610 → $560 | $599.69 | -6.62% | 10 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $115 | $89.41 | +28.62% | 18 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $290 → $180 | $179.63 | +0.21% | 16 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $280 → $400 | $325.00 | +23.08% | 19 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $110 → $95 | $72.94 | +30.24% | 3 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $85.21 | - | 3 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $385.70 | - | 21 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $65 → $68 | $72.12 | -5.71% | 10 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $200 | $277.00 | -27.80% | 11 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $570 → $775 | $879.87 | -11.92% | 15 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $397.70 | n/a | 5 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $150 | $108.62 | n/a | 12 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $7.08 | n/a | 5 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $1,060.50 | n/a | 1 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $450 → $520 | $393.38 | n/a | 8 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $150 | $97.78 | n/a | 15 | May 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $665 → $770 | $1,231.94 | n/a | 9 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $265 → $300 | $417.20 | n/a | 5 | Nov 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $115 → $125 | $130.92 | n/a | 10 | Jun 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $75 | $133.06 | n/a | 11 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $64.84 | n/a | 6 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $115 → $140 | $247.97 | n/a | 14 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $156.79 | n/a | 2 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $237.18 | n/a | 10 | Aug 27, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $207.13 | n/a | 1 | Feb 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $19 | $5.00 | n/a | 3 | Oct 21, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $27.78 | n/a | 3 | Aug 15, 2016 |
HCA Healthcare
Aug 7, 2026
Maintained: Buy
Price Target: $500
Current: $414.03
Upside: +20.76%
Pfizer
Aug 5, 2026
Maintained: Buy
Price Target: n/a
Current: $27.05
Upside: -
Boston Scientific
Jul 30, 2026
Downgraded: Hold
Price Target: n/a
Current: $50.46
Upside: -
Johnson & Johnson
Jul 28, 2026
Rated: Buy
Price Target: $210 → $300
Current: $261.81
Upside: +14.59%
Quest Diagnostics
Jul 28, 2026
Maintained: Buy
Price Target: $175 → $260
Current: $237.63
Upside: +9.41%
Danaher
Jul 23, 2026
Rated: Buy
Price Target: $230
Current: $209.37
Upside: +9.85%
UnitedHealth Group
Jul 17, 2026
Maintained: Buy
Price Target: $400 → $470
Current: $408.74
Upside: +14.99%
Stryker
Jul 9, 2026
Rated: Buy
Price Target: $450 → $370
Current: $345.81
Upside: +7.00%
Integra LifeSciences Holdings
Jun 17, 2026
Upgraded: Buy
Price Target: $25
Current: $17.07
Upside: +46.46%
Labcorp Holdings
Jun 2, 2026
Maintained: Buy
Price Target: $310
Current: $321.31
Upside: -3.52%
May 29, 2026
Maintained: Buy
Price Target: n/a
Current: $241.99
Upside: -
May 21, 2026
Maintained: Buy
Price Target: n/a
Current: $92.03
Upside: -
Apr 30, 2026
Maintained: Buy
Price Target: $610 → $560
Current: $599.69
Upside: -6.62%
Apr 6, 2026
Maintained: Buy
Price Target: $115
Current: $89.41
Upside: +28.62%
Mar 20, 2026
Rated: Buy
Price Target: $290 → $180
Current: $179.63
Upside: +0.21%
Mar 17, 2026
Reiterated: Buy
Price Target: $280 → $400
Current: $325.00
Upside: +23.08%
Mar 3, 2026
Rated: Buy
Price Target: $110 → $95
Current: $72.94
Upside: +30.24%
Dec 12, 2025
Maintained: Buy
Price Target: n/a
Current: $85.21
Upside: -
Dec 8, 2025
Maintained: Hold
Price Target: n/a
Current: $385.70
Upside: -
Nov 20, 2025
Rated: Buy
Price Target: $65 → $68
Current: $72.12
Upside: -5.71%
Nov 17, 2025
Upgraded: Buy
Price Target: $200
Current: $277.00
Upside: -27.80%
Aug 20, 2025
Rated: Buy
Price Target: $570 → $775
Current: $879.87
Upside: -11.92%
Jul 21, 2025
Downgraded: Hold
Price Target: n/a
Current: $397.70
Upside: n/a
Apr 21, 2025
Maintained: Buy
Price Target: $150
Current: $108.62
Upside: n/a
Mar 26, 2025
Maintained: Hold
Price Target: n/a
Current: $7.08
Upside: n/a
Aug 15, 2024
Rated: Buy
Price Target: n/a
Current: $1,060.50
Upside: n/a
Jul 23, 2024
Maintained: Buy
Price Target: $450 → $520
Current: $393.38
Upside: n/a
May 20, 2024
Upgraded: Buy
Price Target: $150
Current: $97.78
Upside: n/a
Feb 7, 2024
Maintained: Buy
Price Target: $665 → $770
Current: $1,231.94
Upside: n/a
Nov 6, 2023
Maintained: Buy
Price Target: $265 → $300
Current: $417.20
Upside: n/a
Jun 6, 2023
Maintained: Buy
Price Target: $115 → $125
Current: $130.92
Upside: n/a
Jan 28, 2022
Upgraded: Buy
Price Target: $75
Current: $133.06
Upside: n/a
Nov 1, 2021
Downgraded: Hold
Price Target: n/a
Current: $64.84
Upside: n/a
Aug 5, 2021
Maintained: Buy
Price Target: $115 → $140
Current: $247.97
Upside: n/a
Mar 10, 2021
Downgraded: Hold
Price Target: n/a
Current: $156.79
Upside: n/a
Aug 27, 2019
Downgraded: Hold
Price Target: n/a
Current: $237.18
Upside: n/a
Feb 16, 2018
Downgraded: Hold
Price Target: n/a
Current: $207.13
Upside: n/a
Oct 21, 2016
Reiterated: Buy
Price Target: $17 → $19
Current: $5.00
Upside: n/a
Aug 15, 2016
Maintained: Hold
Price Target: n/a
Current: $27.78
Upside: n/a